{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T20:54:46Z","timestamp":1776459286092,"version":"3.51.2"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Complementary Therapies in Medicine"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ctim.2024.103018","type":"journal-article","created":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T03:20:06Z","timestamp":1704511206000},"page":"103018","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["What is the influence of policosanol supplementation on liver enzymes? A systematic review and dose-response meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"80","author":[{"given":"Afsaneh","family":"Gholamrezayi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Amini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niloufar","family":"Rasaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camellia","family":"Akhgarjand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Kalantar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gholamreza","family":"Askari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azita","family":"Hekmatdoost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ctim.2024.103018_bib1","first-page":"117","article-title":"The de ritis ratio: the test of time","volume":"34","author":"Botros","year":"2013","journal-title":"Clin Biochem Rev"},{"issue":"17","key":"10.1016\/j.ctim.2024.103018_bib2","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1056\/NEJM200004273421707","article-title":"Evaluation of abnormal liver-enzyme results in asymptomatic patients","volume":"342","author":"Pratt","year":"2000","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ctim.2024.103018_bib3","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/j.gastro.2008.10.052","article-title":"Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population","volume":"136","author":"Ruhl","year":"2009","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ctim.2024.103018_bib4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/j.gastro.2007.10.024","article-title":"Impact of fatty liver disease on health care utilization and costs in a general population: a 5-year observation","volume":"134","author":"Baumeister","year":"2008","journal-title":"Gastroenterology"},{"issue":"7446","key":"10.1016\/j.ctim.2024.103018_bib5","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/bmj.38050.593634.63","article-title":"Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study","volume":"328","author":"Kim","year":"2004","journal-title":"BMJ (Clinical research ed)"},{"key":"10.1016\/j.ctim.2024.103018_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d6891","article-title":"Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study","volume":"343","author":"Lazo","year":"2011","journal-title":"BMJ (Clinical research ed)"},{"key":"10.1016\/j.ctim.2024.103018_bib7","series-title":"Serum liver enzymes\u2010should we count on them?","first-page":"171","volume":"34","author":"Oren","year":"2014"},{"issue":"11","key":"10.1016\/j.ctim.2024.103018_bib8","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1210\/jc.2006-1010","article-title":"Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat","volume":"91","author":"Burgert","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.ctim.2024.103018_bib9","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1210\/jc.2007-0482","article-title":"Liver fat in the metabolic syndrome","volume":"92","author":"Kotronen","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ctim.2024.103018_bib10","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.2337\/diabetes.51.6.1889","article-title":"High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes","volume":"51","author":"Vozarova","year":"2002","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.ctim.2024.103018_bib11","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/s12072-013-9476-6","article-title":"Elevated ALT and GGT predict all-cause mortality and hepatocellular carcinoma in Taiwanese male: a case-cohort study","volume":"7","author":"Hernaez","year":"2013","journal-title":"Hepatol Int"},{"issue":"3","key":"10.1016\/j.ctim.2024.103018_bib12","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1177\/1756283X16638830","article-title":"Lifestyle changes for the treatment of nonalcoholic fatty liver disease: a review of observational studies and intervention trials","volume":"9","author":"Zelber-Sagi","year":"2016","journal-title":"Therap Adv Gastroenterol"},{"issue":"3","key":"10.1016\/j.ctim.2024.103018_bib13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5114\/ceh.2018.78118","article-title":"Recommendations for the management of non-alcoholic fatty liver disease (NAFLD)","volume":"4","author":"Tomasiewicz","year":"2018","journal-title":"Clin Exp Hepatol"},{"issue":"3\u20134","key":"10.1016\/j.ctim.2024.103018_bib14","first-page":"205","article-title":"Cholesterol-lowering effects of policosanol in rabbits","volume":"27","author":"Arruzazabala","year":"1994","journal-title":"Biol Res"},{"issue":"3","key":"10.1016\/j.ctim.2024.103018_bib15","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1124\/jpet.106.107144","article-title":"Policosanol inhibits cholesterol synthesis in hepatoma cells by activation of AMP-kinase","volume":"318","author":"Singh","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.ctim.2024.103018_bib16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/jat.705","article-title":"One-year dog toxicity study of D-002, a mixture of aliphatic alcohols","volume":"21","author":"Alem\u00e1n","year":"2001","journal-title":"J Appl Toxicol: JAT"},{"issue":"2","key":"10.1016\/j.ctim.2024.103018_bib17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11745-003-1047-3","article-title":"Effects of policosanols and phytosterols on lipid levels and cholesterol biosynthesis in hamsters","volume":"38","author":"Wang","year":"2003","journal-title":"Lipids"},{"issue":"1","key":"10.1016\/j.ctim.2024.103018_bib18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0188-4409(00)00265-4","article-title":"Policosanol modulates HMG-CoA reductase activity in cultured fibroblasts","volume":"32","author":"Men\u00e9ndez","year":"2001","journal-title":"Arch Med Res"},{"issue":"9","key":"10.1016\/j.ctim.2024.103018_bib19","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0011-393X(05)80279-6","article-title":"One-year efficacy and safety of policosanol in patients with type II hypercholesterolemia","volume":"55","author":"Pons","year":"1994","journal-title":"Curr Ther Res"},{"issue":"6725","key":"10.1016\/j.ctim.2024.103018_bib20","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/bmj.300.6725.667","article-title":"Lipid lowering drugs","volume":"300","author":"O\u2019Connor","year":"1990","journal-title":"BMJ (Clinical research ed)"},{"issue":"2","key":"10.1016\/j.ctim.2024.103018_bib21","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2165\/00002018-199106020-00003","article-title":"A comparative review of the adverse effects of treatments for hyperlipidaemia","volume":"6","author":"Steiner","year":"1991","journal-title":"Drug Saf"},{"issue":"7","key":"10.1016\/j.ctim.2024.103018_bib22","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0011-393X(96)80068-3","article-title":"Effects of policosanol on hypercholesterolemic patients with abnormal serum biochemical indicators of hepatic function","volume":"57","author":"Zardoya","year":"1996","journal-title":"Curr Ther Res"},{"issue":"4","key":"10.1016\/j.ctim.2024.103018_bib23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2165\/00126839-200506040-00003","article-title":"Effects of addition of policosanol to omega-3 fatty acid therapy on the lipid profile of patients with type II hypercholesterolaemia","volume":"6","author":"Casta\u00f1o","year":"2005","journal-title":"Drugs in R&D"},{"issue":"10","key":"10.1016\/j.ctim.2024.103018_bib24","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.metabol.2004.05.006","article-title":"Wheat germ policosanol failed to lower plasma cholesterol in subjects with normal to mildly elevated cholesterol concentrations","volume":"53","author":"Lin","year":"2004","journal-title":"Metab Clin Exp"},{"issue":"4","key":"10.1016\/j.ctim.2024.103018_bib25","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0009-9236(99)70139-6","article-title":"Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors","volume":"65","author":"M\u00e1s","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ctim.2024.103018_bib26","first-page":"n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clinical research ed)"},{"key":"10.1016\/j.ctim.2024.103018_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctim.2020.102337","article-title":"Effects of berberine and barberry on anthropometric measures: A systematic review and meta-analysis of randomized controlled trials","volume":"49","author":"Amini","year":"2020","journal-title":"Complement Ther Med"},{"issue":"7414","key":"10.1016\/j.ctim.2024.103018_bib28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Bmj"},{"issue":"2","key":"10.1016\/j.ctim.2024.103018_bib29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.14740\/jem642","article-title":"Effects of policosanol in patients with metabolic syndrome: A six-month study","volume":"10","author":"Arteche-Hidalgo","year":"2020","journal-title":"J Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ctim.2024.103018_bib30","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.amjms.2018.06.014","article-title":"Efficacy and Safety of Policosanol Plus Fenofibrate Combination Therapy in Elderly Patients with Mixed Dyslipidemia: A Randomized, Controlled Clinical Study","volume":"356","author":"Wang","year":"2018","journal-title":"Am J Med Sci"},{"issue":"9a","key":"10.1016\/j.ctim.2024.103018_bib31","doi-asserted-by":"crossref","first-page":"44K","DOI":"10.1016\/j.amjcard.2005.08.007","article-title":"Pharmacokinetic interactions between statins and fibrates","volume":"96","author":"Corsini","year":"2005","journal-title":"Am J Cardiol"},{"issue":"15","key":"10.1016\/j.ctim.2024.103018_bib32","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.1021\/jf060688k","article-title":"Policosanol content and composition in perilla seeds","volume":"54","author":"Adhikari","year":"2006","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.ctim.2024.103018_bib33","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s11745-009-3338-y","article-title":"Regulation of HMGCoA reductase activity by policosanol and octacosadienol, a new synthetic analogue of octacosanol","volume":"44","author":"Oliaro-Bosso","year":"2009","journal-title":"Lipids"},{"key":"10.1016\/j.ctim.2024.103018_bib34","doi-asserted-by":"crossref","first-page":"541.523","DOI":"10.1096\/fasebj.24.1_supplement.541.23","article-title":"Tea and policosanol act through different mechanisms to activate AMP\u2010kinase and suppress HMG\u2010CoA reductase to inhibit cholesterol synthesis","volume":"24","author":"Banerjee","year":"2010","journal-title":"FASEB J"},{"issue":"2","key":"10.1016\/j.ctim.2024.103018_bib35","first-page":"30","article-title":"Policosanol for managing human immunodeficiency virus-related dyslipidemia in a medically underserved population: a randomized, controlled clinical trial","volume":"17","author":"Swanson","year":"2011","journal-title":"Altern Ther Health Med"},{"issue":"3","key":"10.1016\/j.ctim.2024.103018_bib36","doi-asserted-by":"crossref","first-page":"M186","DOI":"10.1093\/gerona\/56.3.M186","article-title":"Effects of policosanol in older patients with type II hypercholesterolemia and high coronary risk.","volume":"56","author":"Casta\u00f1o","year":"2001","journal-title":"J Gerontol Ser A, Biol Sci Med Sci"},{"issue":"3\u20134","key":"10.1016\/j.ctim.2024.103018_bib37","first-page":"89","article-title":"Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus","volume":"22","author":"Casta\u00f1o","year":"2002","journal-title":"Int J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.ctim.2024.103018_bib38","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-2125.2000.00250.x","article-title":"Effects of policosanol treatment on the susceptibility of low density lipoprotein (LDL) isolated from healthy volunteers to oxidative modification in vitro","volume":"50","author":"Men\u00e9ndez","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ctim.2024.103018_bib39","first-page":"12","article-title":"Hepatoprotective properties of Penthorum chinense Pursh against carbon tetrachloride-induced acute liver injury in mice","author":"Wang","year":"2017","journal-title":"Chin Med"},{"issue":"4","key":"10.1016\/j.ctim.2024.103018_bib40","first-page":"105","article-title":"Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients","volume":"19","author":"Castano","year":"1999","journal-title":"Int J Clin Pharmacol Res"},{"issue":"4","key":"10.1016\/j.ctim.2024.103018_bib41","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2042-7158.1995.tb05797.x","article-title":"Effect of policosanol on lipofundin-induced atherosclerotic lesions in rats","volume":"47","author":"Noa","year":"1995","journal-title":"J Pharm Pharmacol"},{"issue":"8","key":"10.1016\/j.ctim.2024.103018_bib42","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.curtheres.2003.09.002","article-title":"Effects of policosanol on borderline to mildly elevated serum total cholesterol levels: a prospective, double-blind, placebo-controlled, parallel-group, comparative study","volume":"64","author":"Casta\u00f1o","year":"2003","journal-title":"Curr Ther Res"},{"issue":"2","key":"10.1016\/j.ctim.2024.103018_bib43","first-page":"107","article-title":"Concomitant use of policosanol and benzodiazepines in older patients","volume":"38","author":"Casta\u00f1o","year":"2007","journal-title":"Rev CENIC Cienc Biol\u00f3gicas"},{"key":"10.1016\/j.ctim.2024.103018_bib44","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/00126839-200203030-00004","article-title":"Effects of policosanol on older patients with hypertension and type II hypercholesterolaemia","volume":"3","author":"Casta\u00f1o","year":"2002","journal-title":"Drugs R D"},{"issue":"7","key":"10.1016\/j.ctim.2024.103018_bib45","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0011-393X(96)80068-3","article-title":"Effects of policosanol on hypercholesterolemic patients with abnormal serum biochemical indicators of hepatic function","volume":"57","author":"Zardoya","year":"1996","journal-title":"Curr Ther Res"},{"issue":"6","key":"10.1016\/j.ctim.2024.103018_bib46","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.3390\/ijms24065185","volume":"24","author":"Cho","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.ctim.2024.103018_bib47","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.metabol.2004.05.006","article-title":"Wheat germ policosanol failed to lower plasma cholesterol in subjects with normal to mildly elevated cholesterol concentrations","volume":"53","author":"Lin","year":"2004","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.ctim.2024.103018_bib48","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jhep.2011.07.028","article-title":"Endogenous formation of N\u03b5-(carboxymethyl) lysine is increased in fatty livers and induces inflammatory markers in an in vitro model of hepatic steatosis","volume":"56","author":"Gaens","year":"2012","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.ctim.2024.103018_bib49","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.clinbiochem.2005.07.016","article-title":"Elevation of N\u03b5-(carboxymethyl) lysine-modified advanced glycation end products in chronic liver disease is an indicator of liver cirrhosis","volume":"39","author":"Yagmur","year":"2006","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ctim.2024.103018_bib50","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.clinbiochem.2005.07.016","article-title":"Elevation of Nepsilon-(carboxymethyl) lysine-modified advanced glycation end products in chronnic liver diseasis an indicator of liver cirrhosis","volume":"39","author":"Ya\u011fmur","year":"2006","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ctim.2024.103018_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113020","article-title":"Oral supplementation of policosanol alleviates carbon tetrachloride-induced liver fibrosis in rats","volume":"150","author":"Zein","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ctim.2024.103018_bib52","first-page":"1","article-title":"Hepatoprotective effect and potential mechanism of aqueous extract from Phyllanthus emblica on carbon-tetrachloride-induced liver fibrosis in rats","volume":"2021","author":"Yin","year":"2021","journal-title":"Evid-Based Complement Altern Med"},{"key":"10.1016\/j.ctim.2024.103018_bib53","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2165\/00044011-200323100-00003","article-title":"Comparison of the effects of policosanol and atorvastatin on lipid profile and platelet aggregation in patients with dyslipidaemia and type 2 diabetes mellitus","volume":"23","author":"Castano","year":"2003","journal-title":"Clin Drug Investig"},{"issue":"2","key":"10.1016\/j.ctim.2024.103018_bib54","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/0011-393X(95)85043-0","article-title":"Effect of policosanol in lowering cholesterol levels in patients with type II hypercholesterolemia","volume":"56","author":"Aneiros","year":"1995","journal-title":"Curr Ther Res"}],"container-title":["Complementary Therapies in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229924000062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229924000062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T18:32:18Z","timestamp":1748284338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0965229924000062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":54,"alternative-id":["S0965229924000062"],"URL":"https:\/\/doi.org\/10.1016\/j.ctim.2024.103018","relation":{},"ISSN":["0965-2299"],"issn-type":[{"value":"0965-2299","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What is the influence of policosanol supplementation on liver enzymes? A systematic review and dose-response meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Complementary Therapies in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctim.2024.103018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103018"}}